Dixon D - Search Results

1

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.

Romaguera JE, McLaughlin P, North L, Dixon D, Silvermintz KB, Garnsey LA, Velasquez WS, Hagemeister FB, Cabanillas F. Romaguera JE, et al. Among authors: dixon d. J Clin Oncol. 1991 May;9(5):762-9. doi: 10.1200/JCO.1991.9.5.762. J Clin Oncol. 1991. PMID: 1707956

2

Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.

Hagemeister FB, Fuller LM, Velasquez WS, McLaughlin P, Redman JR, Swan F, Rodriguez MA, North L, Dixon D, Silvermintz K, et al. Hagemeister FB, et al. Among authors: dixon d. Ann Oncol. 1991 Jan;2(1):25-31. doi: 10.1093/oxfordjournals.annonc.a057819. Ann Oncol. 1991. PMID: 2009233 Free article.

3

Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.

Spinolo JA, Cabanillas F, Dixon DO, Khorana SM, McLaughlin P, Velasquez WS, Hagemeister FB, Redman JR, Swan F Jr. Spinolo JA, et al. Among authors: dixon do. Ann Oncol. 1992 Mar;3(3):227-32. doi: 10.1093/oxfordjournals.annonc.a058157. Ann Oncol. 1992. PMID: 1586621 Free article.

4

Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen.

McLaughlin P, Fuller LM, Velasquez WS, Butler JJ, Hagemeister FB, Sullivan-Halley JA, Dixon DO. McLaughlin P, et al. Among authors: dixon do. J Clin Oncol. 1987 Jun;5(6):867-74. doi: 10.1200/JCO.1987.5.6.867. J Clin Oncol. 1987. PMID: 3295130

5

Reporting outcomes in Hodgkin's disease and lymphoma.

Dixon DO, McLaughlin P, Hagemeister FB, Freireich EJ, Fuller LM, Cabanillas FF, Gehan EA. Dixon DO, et al. J Clin Oncol. 1987 Oct;5(10):1670-2. doi: 10.1200/JCO.1987.5.10.1670. J Clin Oncol. 1987. PMID: 3655864 No abstract available.

6

Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.

Kantarjian HM, McLaughlin P, Fuller LM, Dixon DO, Osborne BM, Cabanillas FF. Kantarjian HM, et al. Among authors: dixon do. J Clin Oncol. 1984 Jul;2(7):811-9. doi: 10.1200/JCO.1984.2.7.811. J Clin Oncol. 1984. PMID: 6376721

7

Prognostic factors with high-dose melphalan for refractory multiple myeloma.

Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F. Barlogie B, et al. Among authors: dixon d. Blood. 1988 Dec;72(6):2015-9. Blood. 1988. PMID: 3196876 Free article.

8

A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission.

Zander AR, Keating M, Dicke K, Dixon D, Pierce S, Jagannath S, Peters L, Horwitz L, Cockerill K, Spitzer G, et al. Zander AR, et al. Among authors: dixon d. J Clin Oncol. 1988 Oct;6(10):1548-57. doi: 10.1200/JCO.1988.6.10.1548. J Clin Oncol. 1988. PMID: 3049949

9

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

Dixon DO, Neilan B, Jones SE, Lipschitz DA, Miller TP, Grozea PN, Wilson HE. Dixon DO, et al. J Clin Oncol. 1986 Mar;4(3):295-305. doi: 10.1200/JCO.1986.4.3.295. J Clin Oncol. 1986. PMID: 3512783 Clinical Trial.

10

Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.

Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ. Ventura GJ, et al. Among authors: dixon do. Hematol Pathol. 1989;3(1):23-8. Hematol Pathol. 1989. PMID: 2745357

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,025 results

Search Page

Filters